Thyrocare Technologies informs about execution of BTA

30 Aug 2024 Evaluate

Thyrocare Technologies has informed that the Company has entered into Business Transfer Agreement (‘BTA’) on August 30, 2024, around 11.00 am with, Vimta Labs, by which the Company would be acquiring Vimta’s diagnostic and pathological services business as a going concern (on a slump sale basis). Completion of the said acquisition is subject to fulfilment of the Conditions Precedent (‘CP’). Details required under Regulation 30 of the Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are given in the Disclosure Sheet attached as Annexure - 1 to this Letter.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

970.35 5.65 (0.59%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6743.65
Max Healthcare Inst 989.65
Narayana Hrudayalay 1259.00
Aster DM Healthcare 426.55
Global Health 1072.45
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.